Want to see AAPG full AI Analyst Report?
Ascentage Pharma Group International Unsponsored ADR (AAPG) Income Statement
Ascentage Pharma Group International Unsponsored ADR Income Statement
Last quarter (Q2 2026), Ascentage Pharma Group International Unsponsored ADR's total revenue was $298.88M, a decrease of 63.72% from the same quarter last year. In Q2, Ascentage Pharma Group International Unsponsored ADR's net income was $-807.68M. See Ascentage Pharma Group International Unsponsored ADR’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 558.48M | $ 980.65M | $ 221.98M | $ 209.71M | $ 27.91M | |
| $ 426.75M | $ 951.57M | $ 191.44M | $ 187.71M | $ 24.58M | |
| $ 1.61B | $ 1.32B | $ 1.06B | $ 1.04B | $ 957.75M | |
| Depreciation and Amortization | $ 86.48M | $ 93.17M | $ 93.19M | $ 62.91M | $ 28.33M |
| $ -1.09B | $ -237.63M | $ -743.61M | $ -771.47M | $ -787.19M | |
| $ -1.18B | $ -369.73M | $ -872.64M | $ -849.81M | $ -869.84M | |
| $ -23.21M | $ -25.52M | $ -60.23M | $ -37.36M | $ 37.59M | |
| $ -1.20B | $ -395.25M | $ -932.86M | $ -887.17M | $ -832.25M | |
| $ -1.21B | $ -405.43M | $ -925.64M | $ -882.92M | $ -782.42M | |
| Per Share Metrics | |||||
| Basic EPS | $ -13.56 | $ -5.36 | $ -52.48 | $ -53.60 | $ -49.12 |
| Diluted EPS | $ -13.56 | $ -5.36 | $ -52.48 | $ -53.60 | $ -49.12 |
| Weighted Average Shares Outstanding | 89.03M | 75.52M | 17.64M | 16.48M | 15.91M |
| Weighted Average Shares Outstanding (Diluted) | 89.03M | 75.52M | 17.64M | 16.48M | 15.91M |
Currency in CNY